Search

everythinglearnresearchcommunity

for

Search:↓

Research 7 of 175

1. Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer Annals of oncology · 2004 · 1461 citations
2. Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer Anti-cancer drugs · 2000 · 81 citations
3. Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma Cancer · 2000 · 388 citations
4. UTMD Enhances Targeting of Diclofenac and Doxil® to Boost Tumor Immunotherapy Ultrasound in Medicine & Biology · 2025
5. Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy Cancer investigation · 2001 · 522 citations
6. Folliculotropic CD8+ mycosis fungoides associated with diffuse mucosal involvement JAAD case reports · 2018 · 2 citations
7. Copper−Doxorubicin as a Nanoparticle Cargo Retains Efficacy with Minimal Toxicity Molecular Pharmaceutics · 2010 · 102 citations

Community

— no results